Synergy Innovation Co. Ltd Total Assets
Synergy Innovation Co. Ltd total assets. Based on the latest financial reports, Synergy Innovation Co. Ltd (048870) holds total assets worth ₩345.29 Billion KRW (≈ $234.00 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Synergy Innovation Co. Ltd market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Synergy Innovation Co. Ltd (2006–2025)
Total assets of Synergy Innovation Co. Ltd from 2006 to 2025. This chart illustrates how Synergy Innovation Co. Ltd's total assets have evolved over time, based on quarterly financial data. See 048870 stock price and chart for real-time trading data and today's change.
Synergy Innovation Co. Ltd - Asset Composition Analysis
Synergy Innovation Co. Ltd Total Assets Breakdown (December 2025)
Synergy Innovation Co. Ltd total assets breakdown as of December 2025. Synergy Innovation Co. Ltd's total assets of ₩345.29 Billion consist of 50.9% current assets and 49.2% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 19.5% |
| Accounts Receivable | ₩19.47 Billion | 5.8% |
| Inventory | ₩22.49 Billion | 6.7% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩5.11 Billion | 1.5% |
| Goodwill | ₩16.12 Billion | 4.8% |
Asset Composition Trend (2006–2025)
This chart illustrates how Synergy Innovation Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Synergy Innovation Co. Ltd current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Synergy Innovation Co. Ltd's current assets represent 50.9% of total assets in 2025, an increase from 0.0% in 2006.
- Cash Position: Cash and equivalents constituted 19.5% of total assets in 2025, down from 24.0% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, a decrease from 19.0% in 2006.
- Asset Diversification: The largest asset category is inventory at 6.7% of total assets.
Synergy Innovation Co. Ltd Competitors by Total Assets
Key competitors of Synergy Innovation Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hyloris Developmentsen Sa
BR:HYL
|
Belgium | €37.05 Million |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Oruka Therapeutics, Inc.
NASDAQ:ORKA
|
USA | $1.14 Billion |
|
Gempharmatech Co. Ltd. A
SHG:688046
|
China | CN¥2.80 Billion |
|
Vor Biopharma Inc
NASDAQ:VOR
|
USA | $481.05 Million |
|
Inventiva S.A
PA:IVA
|
France | €249.51 Million |
|
Sunmax Biotechnology Co Ltd
TWO:4728
|
Taiwan | NT$1.90 Billion |
|
Apnimed, Inc. Common Stock
NASDAQ:APMD
|
USA | $342.63 Million |
Synergy Innovation Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.19 | 2.66 | 1.69 |
| Quick Ratio | 3.62 | 2.27 | 1.45 |
| Cash Ratio | 0.00 | 0.00 | 0.75 |
| Working Capital | ₩144.39 Billion | ₩92.00 Billion | ₩36.28 Billion |
Synergy Innovation Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Synergy Innovation Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.59 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 7.3% |
| Total Assets | ₩336.89 Billion |
| Market Capitalization | $80.73 Million USD |
Valuation Analysis
Below Book Valuation: The market values Synergy Innovation Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Synergy Innovation Co. Ltd's assets grew by 7.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Synergy Innovation Co. Ltd (2006–2025)
The table below shows the annual total assets of Synergy Innovation Co. Ltd from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩336.89 Billion ≈ $228.30 Million |
+7.27% |
| 2024-12-31 | ₩314.06 Billion ≈ $212.83 Million |
+9.85% |
| 2023-12-31 | ₩285.90 Billion ≈ $193.75 Million |
+25.74% |
| 2022-12-31 | ₩227.38 Billion ≈ $154.09 Million |
+12.17% |
| 2021-12-31 | ₩202.70 Billion ≈ $137.37 Million |
+28.04% |
| 2020-12-31 | ₩158.31 Billion ≈ $107.29 Million |
+7.48% |
| 2019-12-31 | ₩147.29 Billion ≈ $99.82 Million |
+20.73% |
| 2018-12-31 | ₩122.01 Billion ≈ $82.68 Million |
+15.03% |
| 2017-12-31 | ₩106.06 Billion ≈ $71.87 Million |
+77.73% |
| 2016-12-31 | ₩59.67 Billion ≈ $40.44 Million |
+270.69% |
| 2015-12-31 | ₩16.10 Billion ≈ $10.91 Million |
-80.39% |
| 2014-12-31 | ₩82.08 Billion ≈ $55.62 Million |
-15.00% |
| 2013-12-31 | ₩96.56 Billion ≈ $65.44 Million |
-25.84% |
| 2012-12-31 | ₩130.20 Billion ≈ $88.24 Million |
+3.31% |
| 2011-12-31 | ₩126.03 Billion ≈ $85.41 Million |
-11.87% |
| 2009-12-31 | ₩143.00 Billion ≈ $96.91 Million |
-20.32% |
| 2008-12-31 | ₩179.47 Billion ≈ $121.63 Million |
+14.60% |
| 2007-12-31 | ₩156.60 Billion ≈ $106.13 Million |
+14.49% |
| 2006-12-31 | ₩136.78 Billion ≈ $92.69 Million |
-- |
About Synergy Innovation Co. Ltd
Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation " universal transport solutions (SI-UTS); and invests and develops in various fields comprising mic… Read more